Atricure
AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling innovative devices for the surgical ablation of cardiac tissue. Headquartered in Mason, Ohio, the company offers a range of products designed to treat atrial fibrillation and manage left atrial appendage conditions, as well as address post-operative pain. Its product portfolio includes systems such as the Isolator Synergy clamps for atrial fibrillation treatment, the EPi-Sense guided coagulation system, and the COBRA Fusion surgical ablation system, which integrates different energy modalities for enhanced efficacy. AtriCure also provides multifunctional tools for cardiac arrhythmia evaluation and management, as well as cryoablation systems for targeted tissue ablation. The company emphasizes minimally invasive techniques, catering to the trend toward less invasive cardiac and thoracic surgeries. AtriCure primarily serves medical centers in the United States and internationally through a combination of direct sales and independent distributors. Founded in 2000, AtriCure remains committed to advancing surgical treatments in the cardiac field.
SentreHEART, Inc., based in Redwood City, California, is a privately held medical device company that manufacturers the LARIAT Suture Delivery Device for remote delivery of a pre-tied suture loop. Innovation in catheter and suture delivery technology enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind. Regulatory clearance for soft tissue ligation and approximation has been received in the US, Europe, and Canada.
nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris® Coagulation System with VisiTrax® is based on the unique integration of suction, perfusion, and RF energy to ensure the creation of visible, nonconductive, continuous, bi-atrial lesions on the epicardium of a beating heart. To date, the Numeris® Coagulation System with VisiTrax® is indicated for endoscopic coagulation of cardiac tissue in the United States. nContact has initiated IDE clinical studies for the treatment of AF in both open and closed chest procedures. The Numeris Coagulation System with VisiTrax has CE Mark approval in Europe for the coagulation of cardiac tissue for the treatment of AF and atrial flutter.
ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.